Iron metabolism and infection - PubMed (original) (raw)
Review
. 2007 Dec;28(4 Suppl):S515-23.
doi: 10.1177/15648265070284S405.
Affiliations
- PMID: 18297890
- DOI: 10.1177/15648265070284S405
Review
Iron metabolism and infection
Colin Ratledge. Food Nutr Bull. 2007 Dec.
Abstract
The review highlights the intrinsic problems in the acquisition of ferric iron (FeIII) by pathogenic microorganisms, and bacteria in particular, during their infection of animals. Acquisition of iron from host sources, such as ferritin, transferrin, and heme compounds, is discussed. Acquisition can be by direct contact, via a surface receptor protein of the bacterium, with one of the iron-containing compounds, but more frequently iron is acquired by the production of a siderophore. Over 500 different siderophores are now known; they work by having a superior binding power to that of the host iron-containing materials. They literally strip the iron out of these molecules. They are low-molecular-weight (< 1,000 Da) compounds that are produced in response to iron deprivation, which is a primary host defense mechanism against infections. The iron-siderophore complex is small enough to be taken up into the bacterial cells, usually via an active transport process; the iron is removed from the siderophore, normally by a reductive process, and is then incorporated into the various apoproteins of the bacterial cell or is stored within the bacteria in the form of bacterioferritin. To combat the effectiveness of the siderophores, animals may synthesize specific proteins to bind and nullify their action. The role of one such protein, siderocalin (= lipocalin 2), is discussed. However, these countermeasures have, in turn, been thwarted by at least one bacterium, Salmonella, glycosylating its siderophore (enterobactin/enterochelin) so that binding of the modified siderophore (now termed salmochelin) with lipocalin can no longer occur.
Similar articles
- Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.
Wilson BR, Bogdan AR, Miyazawa M, Hashimoto K, Tsuji Y. Wilson BR, et al. Trends Mol Med. 2016 Dec;22(12):1077-1090. doi: 10.1016/j.molmed.2016.10.005. Epub 2016 Nov 4. Trends Mol Med. 2016. PMID: 27825668 Free PMC article. Review. - Diverging roles of bacterial siderophores during infection.
Holden VI, Bachman MA. Holden VI, et al. Metallomics. 2015 Jun;7(6):986-95. doi: 10.1039/c4mt00333k. Metallomics. 2015. PMID: 25745886 Review. - Interaction of lipocalin 2, transferrin, and siderophores determines the replicative niche of Klebsiella pneumoniae during pneumonia.
Bachman MA, Lenio S, Schmidt L, Oyler JE, Weiser JN. Bachman MA, et al. mBio. 2012 Nov 20;3(6):e00224-11. doi: 10.1128/mBio.00224-11. mBio. 2012. PMID: 23169997 Free PMC article. - Salmochelin, the long-overlooked catecholate siderophore of Salmonella.
Müller SI, Valdebenito M, Hantke K. Müller SI, et al. Biometals. 2009 Aug;22(4):691-5. doi: 10.1007/s10534-009-9217-4. Epub 2009 Feb 13. Biometals. 2009. PMID: 19214756 Review. - Iron metabolism in pathogenic bacteria.
Ratledge C, Dover LG. Ratledge C, et al. Annu Rev Microbiol. 2000;54:881-941. doi: 10.1146/annurev.micro.54.1.881. Annu Rev Microbiol. 2000. PMID: 11018148 Review.
Cited by
- The dormant blood microbiome in chronic, inflammatory diseases.
Potgieter M, Bester J, Kell DB, Pretorius E. Potgieter M, et al. FEMS Microbiol Rev. 2015 Jul;39(4):567-91. doi: 10.1093/femsre/fuv013. Epub 2015 May 3. FEMS Microbiol Rev. 2015. PMID: 25940667 Free PMC article. Review. - Th17 cytokines and host-pathogen interactions at the mucosa: dichotomies of help and harm.
Liu JZ, Pezeshki M, Raffatellu M. Liu JZ, et al. Cytokine. 2009 Oct-Nov;48(1-2):156-60. doi: 10.1016/j.cyto.2009.07.005. Epub 2009 Aug 7. Cytokine. 2009. PMID: 19665391 Free PMC article. Review. - Generation of Iron-Independent Siderophore-Producing Agaricus bisporus through the Constitutive Expression of hapX.
Kim MS, Ro HS. Kim MS, et al. Genes (Basel). 2021 May 13;12(5):724. doi: 10.3390/genes12050724. Genes (Basel). 2021. PMID: 34067973 Free PMC article. - Study of Iron Piperazine-Based Chelators as Potential Siderophore Mimetics.
Loupias P, Dechamps-Olivier I, Dupont L, Vanlemmens P, Mullié C, Taudon N, Bouchut A, Dassonville-Klimpt A, Sonnet P. Loupias P, et al. Pharmaceuticals (Basel). 2019 Oct 23;12(4):160. doi: 10.3390/ph12040160. Pharmaceuticals (Basel). 2019. PMID: 31652873 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical